Inositol Isn't Working for You? Look at Absorption, Subtype, and Timing

You did everything right. You bought a 40:1 myo-to-D-chiro blend instead of the flashy high-D-chiro one. You took it twice a day. You waited. And your cycle is still irregular, or your skin hasn't shifted, or the scale hasn't moved — and the internet's only answer is to buy a different, more expensive bottle.

Inositol is the most evidence-supported supplement for PCOS — now PMOS, after the 2026 Lancet renaming — so it's reasonable to expect something. But "most evidenced" is not "works for everyone," and the honest reasons it might not be working for you are worth knowing before you spend money on the next product. There are three, and only one of them means inositol was the wrong tool.

First, the boring answer: it may simply be too early

This is the most common reason, and the least satisfying. Inositol works at the level of the follicle, and an egg takes roughly 90 days to mature. A supplement acting there needs a full cohort of follicles to come through before you can read the result in your cycle. Judging it at three or four weeks tells you almost nothing.

The trials that show benefit generally ran for at least three months, and the effects arrive in a predictable order: energy and cravings can shift in the first few weeks, cycles over two to three months, and skin or hair changes — which follow the slowest biology — often take four to six months. Before concluding inositol failed, give it the full 90 days at the studied dose. A surprising share of "it didn't work" stories are really "I stopped at week five."

The reason almost nobody mentions: you may not be absorbing it

Here is the genuinely useful part. A consistent finding across several studies is that roughly 28 to 38 percent of women with PCOS don't respond to myo-inositol — not because the molecule doesn't work, but because their gut doesn't absorb it well. The term in the literature is "inositol resistance," and it's a transport problem, not a willpower problem. You can take a textbook dose and have very little of it actually reach your bloodstream.

This isn't fringe. A 2018 in-vivo and in-vitro study showed that pairing myo-inositol with alpha-lactalbumin — a whey-derived protein — significantly raised how much myo-inositol made it into circulation. The proposed mechanism is specific: alpha-lactalbumin's digestion products stimulate GLP-2 in the gut, which increases the SGLT-1 and GLUT-2 transporters that ferry inositol across the intestinal wall, and they loosen the tight junctions between gut cells enough to let more through. A 2018 study in confirmed myo-inositol-resistant women found that adding alpha-lactalbumin restored a response in a meaningful share of them, and a 2022 review concluded the combination is a reasonable approach precisely for non-responders.

The practical takeaway: if you've genuinely given plain myo-inositol three months and seen nothing, a myo-inositol-plus-alpha-lactalbumin formulation is the evidence-based next step — not a higher dose, and not switching to D-chiro. (For why more D-chiro tends to backfire, see our myo vs D-chiro breakdown.)

Or you may be treating the wrong driver

Inositol's lever is metabolic. It works through the insulin pathway, helping cells respond to insulin and helping the ovary use glucose. That makes it a strong fit when insulin resistance is what's driving your PMOS — and a weaker fit when something else is.

PMOS varies by underlying driver: for some women it's insulin resistance, for others it's primarily androgen excess, ovulatory dysfunction, low SHBG, or a stress-and-cortisol pattern. If your picture is led by high androgens with normal insulin, or by a stress-driven loss of ovulation, inositol may do relatively little — not because it failed, but because it was aimed at a pathway that isn't your main problem. This is also why a supplement chosen by subtype — spearmint for hyperandrogenic patterns, for instance — sometimes does what inositol couldn't.

How to tell which one you're in

A rough decision guide, not a diagnosis:

• Stopped before 90 days? It's timing. Restart, hold the dose, and re-read at three months.
• Full 90 days, correct 40:1 dose, insulin-resistant picture, still nothing? Absorption is the likeliest culprit. Try a myo-inositol-plus-alpha-lactalbumin formula before concluding inositol doesn't work for you.
• Your PMOS is clearly androgen- or stress-led, not metabolic? You may be using the wrong tool for your driver. The fix is matching the intervention to the driver, not escalating the inositol.

The thread running through all three: "inositol isn't working" is rarely the end of the story. It's usually a question about timing, absorption, or fit — and each has a different answer.

Where to start

Two of these three explanations depend on knowing which version of PMOS you actually have. A picture led by insulin resistance responds very differently from one led by androgens or by a stressed system that's stopped ovulating — and that difference decides whether inositol was ever the right lever, or whether absorption is the thing to fix.

Our free 5-minute assessment walks through your symptom pattern and shows you where you stand, without asking for anything in return.

Citations

• Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026 May 12.
• Monastra G, et al. Alpha-lactalbumin effect on myo-inositol intestinal absorption: in vivo and in vitro. Eur Rev Med Pharmacol Sci. 2018. (PMID 29745333)
• Hernández Marín I, et al. Myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. Journal of Ovarian Research. 2018;11:38.
• Kamenov Z, Gateva A. Positive effects of α-lactalbumin in the management of symptoms of polycystic ovary syndrome. (Review). PMC9370664. 2022.
• Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630.